Parnax Lab

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE383L01019
  • NSEID:
  • BSEID: 506128
INR
120.00
0.7 (0.59%)
BSENSE

Mar 18

BSE+NSE Vol: 610

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Genesis IBRC
Parnax Lab
Panch.Organics
Kimia Bioscien.
Coral Labs.
Alpa Laboratorie
Sotac Pharma.
Natural Capsules
Astonea Labs
Accretion Nutrav
Achyut Healthcar

Why is Parnax Lab Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.32%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Parnax Lab for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Parnax Lab
34.83%
0.73
47.91%
Sensex
1.86%
0.15
12.34%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
19.76%
EBIT Growth (5y)
30.83%
Net Debt to Equity (avg)
0.77
Institutional Holding
0
ROE (avg)
12.32%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
10
Industry P/E
22
Price to Book Value
1.53
EV to EBIT
9.67
EV to EBITDA
7.06
EV to Capital Employed
1.30
EV to Sales
0.90
PEG Ratio
0.42
Dividend Yield
NA
ROCE (Latest)
11.97%
ROE (Latest)
12.26%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
NET SALES(Q)

Highest at Rs 62.94 cr

PAT(Q)

Highest at Rs 3.66 cr.

DEBT-EQUITY RATIO(HY)

Lowest at 0.77 times

DEBTORS TURNOVER RATIO(HY)

Highest at 6.52 times

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Parnax Lab

Net Sales - Quarterly
Highest at Rs 62.94 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 3.66 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 62.94 cr has Grown at 22.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 51.31 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.77 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Highest at 6.52 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio